B.ChaiR.ZhangS.XuS
This collective experience provides valuable guidance beyond marketing materials
Curr Opinion Pharmacol 4:378385 Edelstein R, Tamanaha C, Sheehan P, Miller M, Baselt D, Whitman L, Colton R (2000) The BARC biosensor applied to the detection of biological warfare agents
In some embodiments, the lipid-based drug delivery formulation is a phospholipid-based formulation (e.g., hydrogenated or nonhydrogenated phospholipids, lecithins, phosphatidyl cholines (C8-C18), phosphatidylethanolamines (C8-C18), phosphatidylglycerols (C8-C18)) wherein the phospholipid is phospholipon 90H (1,2-dia-cyl-SN-glycero-3-phosphatidyl choline), egg phospholipids P123, Lipoid E80